Free Spike Antigen ID’d in Post-SARS-CoV-2 mRNA Vaccine Myocarditis
MONDAY, Jan. 9, 2023 (HealthDay News) — Individuals who develop myocarditis following a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine have no difference in vaccine-induced immune responses compared with asymptomatic vaccin…
Learn MoreU.S. Stroke Deaths Fall, But New Rise in Strokes Is Likely
MONDAY, Jan. 9, 2023 (HealthDay News) — U.S. stroke deaths have dramatically declined in the past several decades. But, researchers caution, their new study also found the potential for a resurgence.“After nearly four decades of declining stroke-rela…
Learn MoreFDA Approves Second Alzheimer’s Drug, Despite Safety Concerns
FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients.However, the FDA pointed to the dru…
Learn MoreDamar Hamlin Improving, Alert, Communicating by Writing
FRIDAY, Jan. 6, 2023 (HealthDay News) – While NFL safety Damar Hamlin is still critically ill after suffering cardiac arrest during a game on Monday, he is making a “fairly remarkable recovery,” his doctors said during a news conference on Thursday.“T…
Learn MoreAHA News: Report Highlights Lack of Medical Worker Diversity – And How to Fix That
THURSDAY, Jan. 5, 2023 (American Heart Association News) — Racial and ethnic diversity among medical workers is critical to Americans’ health, but more needs to be done to recruit, train and support those professionals, a new report says.The report, …
Learn MoreUn estudio con teléfonos inteligentes no encuentra efectos cardiacos inusuales con los refuerzos de COVID
MIÉRCOLES, 4 de enero de 2023 (HealthDay News) — Los refuerzos de las vacunas contra la COVID parecen ser del todo seguros para el corazón, muestran unos datos reunidos de casi 5,000 usuarios de teléfonos inteligentes.Los investigadores monitorizaron…
Learn MorePatients, Doctors Await FDA Decision on Experimental Alzheimer’s Drug
THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administrat…
Learn MoreNighttime Hot Spring Bathing May Decrease Prevalence of HTN in Older Adults
THURSDAY, Jan. 5, 2023 (HealthDay News) — Regular nighttime hot spring bathing may prevent hypertension in older adults, according to a Japanese study recently published in Scientific Reports.Satoshi Yamasaki, M.D., Ph.D., from the Kyushu University …
Learn MoreDamar Hamlin Showing ‘Signs of Improvement’ After Cardiac Arrest
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — Damar Hamlin, the Buffalo Bills player who collapsed Monday after suffering cardiac arrest during a game, is showing “signs of improvement,” his team said Wednesday.Still, the 24-year-old “is expected to rem…
Learn More